Clinical trials
Prostatic Neoplasms trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 9 |
| 2014 | 5 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
| Unknown status | 13 |
| Recruiting | 12 |
| Active, not recruiting | 11 |
| Terminated | 8 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Turku University Hospital | 15 |
| Tampere University Hospital | 11 |
| Ferring Pharmaceuticals | 9 |
| Pfizer | 9 |
| AstraZeneca | 8 |
| Bayer | 4 |
| Helsinki University Central Hospital | 4 |
| Blue Earth Diagnostics | 3 |
| GlaxoSmithKline | 3 |
| Lidds AB | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 106 |
| Disease | 4 |
| Genital Neoplasms, Male | 4 |
| Neoplasms | 4 |
| Prostatic Hyperplasia | 4 |
| Urogenital Neoplasms | 4 |
| Neoplasms by Site | 3 |
| Breast Neoplasms | 2 |
| Carcinoma | 2 |
| Genital Diseases, Male | 2 |
Trials
Showing 51 to 75 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.